Kuratani K, Kodama H, Yamaguchi I
Basic Research Group, Tsukuba Research Laboratories, Fujisawa Pharmaceutical Co. Ltd., Ibaraki, Japan.
J Pharmacol Exp Ther. 1994 Aug;270(2):559-65.
Indomethacin (32 mg/kg s.c.) produced mainly antral ulcers in refed rats but almost exclusively corpus erosions in fasted rats. Subcutaneous doses of a nonselective beta (isoproterenol), a selective beta-2 (salbutamol) and selective beta-3 adrenergic agonists CBRL35135, (R*,R*)-(+/-)-methyl 4-[2-[2-hydroxy-2-(3-chlorophenyl)ethylamino]propyl] phenoxyacetate hydrobromide; CL316,243, disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxy-ethyl]- amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate; SR58611A, ethyl[(7S)-7-[(2R)-(2(3-chlorophenyl)-2-hydroxyethylamino]5,6,7, 8-tetrahydronaphthalen-2-yloxy]acetate hydrochloride) dose-dependently attenuated the antral ulcers, and their activities were in the order of BRL35135 (ED50 = 0.03 mg/kg) > CL316,243 (ED50 = 0.04 mg/kg) > SR58611A (ED50 = 0.2 mg/kg) > isoproterenol (ED50 = 0.4 mg/kg) > salbutamol (ED50 = 6 mg/kg). Whereas only isoproterenol, salbutamol and BRL35135 significantly attenuated the corpus erosions and reduced gastric acid secretion in pylorus-ligated rats. In in vitro, all the beta agonists enhanced the beating rate of guinea pig atria (beta-1 action) and inhibited spontaneous contractions of rat uterus (beta-2 action) and colon (beta-3 action). There was found a statistically significant correlation between the IC50 values of the drugs on the colon and ED50 values on the indomethacin-induced antral ulcers (r = 0.97). In addition, the beta agonists excepting salbutamol increased antral gastric mucosal blood flow in rats anesthetized with halothane, and the activities were arranged in the potency order of inhibiting colon motility.(ABSTRACT TRUNCATED AT 250 WORDS)
吲哚美辛(32毫克/千克,皮下注射)在再喂养的大鼠中主要引起胃窦溃疡,但在禁食的大鼠中几乎只引起胃体糜烂。皮下注射非选择性β受体激动剂(异丙肾上腺素)、选择性β2受体激动剂(沙丁胺醇)和选择性β3受体激动剂CBRL35135((R*,R*)-(+/-)-甲基4-[2-[2-羟基-2-(3-氯苯基)乙基氨基]丙基]苯氧基乙酸氢溴酸盐)、CL316,243((R,R)-5-[2-[[2-(3-氯苯基)-2-羟基-乙基]氨基]丙基]-1,3-苯并二恶唑-2,2-二羧酸钠)、SR58611A(乙基[(7S)-7-[(2R)-(2(3-氯苯基)-2-羟基乙氨基]5,6,7,8-四氢萘-2-基氧基]乙酸盐酸盐)剂量依赖性地减轻胃窦溃疡,其活性顺序为BRL35135(半数有效剂量[ED50]=0.03毫克/千克)>CL316,243(ED50=0.04毫克/千克)>SR58611A(ED50=0.2毫克/千克)>异丙肾上腺素(ED50=0.4毫克/千克)>沙丁胺醇(ED50=6毫克/千克)。而只有异丙肾上腺素、沙丁胺醇和BRL35135能显著减轻幽门结扎大鼠的胃体糜烂并减少胃酸分泌。在体外,所有β受体激动剂均能提高豚鼠心房的搏动频率(β1作用),并抑制大鼠子宫(β2作用)和结肠(β3作用)的自发收缩。发现药物对结肠的半数抑制浓度(IC50)值与对吲哚美辛诱导的胃窦溃疡的ED50值之间存在统计学显著相关性(r=0.97)。此外,除沙丁胺醇外的β受体激动剂可增加用氟烷麻醉的大鼠胃窦部胃黏膜血流量,其活性按抑制结肠运动的效力顺序排列。(摘要截选至250字)